Login to Your Account



GSK Labeled Crime Boss, Accused of Bribes in China

By Shannon Ellis
Staff Writer

Wednesday, July 17, 2013
SHANGHAI – Officials in China said a number of executives at Glaxosmithkline plc (GSK) are now officially under investigation "for suspicions of serious economic crimes" that potentially involve deals worth ¥3 billion (US$488 million).

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription